Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Firefly Neuroscience (AIFF) Invested Capital (2016 - 2025)

Historic Invested Capital for Firefly Neuroscience (AIFF) over the last 15 years, with Q3 2025 value amounting to $9.7 million.

  • Firefly Neuroscience's Invested Capital rose 44800.0% to $9.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.7 million, marking a year-over-year increase of 44800.0%. This contributed to the annual value of $452000.0 for FY2024, which is 31467.89% up from last year.
  • According to the latest figures from Q3 2025, Firefly Neuroscience's Invested Capital is $9.7 million, which was up 44800.0% from $12.6 million recorded in Q2 2025.
  • Firefly Neuroscience's 5-year Invested Capital high stood at $17.4 million for Q4 2021, and its period low was -$2.8 million during Q3 2024.
  • For the 5-year period, Firefly Neuroscience's Invested Capital averaged around $5.4 million, with its median value being $3.4 million (2023).
  • Per our database at Business Quant, Firefly Neuroscience's Invested Capital plummeted by 42556.82% in 2024 and then soared by 147464.48% in 2025.
  • Over the past 5 years, Firefly Neuroscience's Invested Capital (Quarter) stood at $17.4 million in 2021, then crashed by 110.33% to -$1.8 million in 2022, then skyrocketed by 106.05% to $109000.0 in 2023, then skyrocketed by 314.68% to $452000.0 in 2024, then surged by 2036.5% to $9.7 million in 2025.
  • Its Invested Capital was $9.7 million in Q3 2025, compared to $12.6 million in Q2 2025 and $5.2 million in Q1 2025.